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A B S T R A C T
Little information is available about the deleterious eﬀect of smoking in older adults The objective of this study
was to assess the relationship of smoking habits with cancer, CVD and all-cause mortality in late middle-age
(45–64 years) and older (65–74) people. This cohort study of 6516 men and 6514 women studied the re-
lationship of smoking habits with cancer, cardiovascular disease (CVD) and all-cause mortality among middle-
aged and older Finnish men and women during 1997–2013. The study cohort was followed up until the end of
2013 (median follow-up time was 11.8 years). Mortality data were obtained from the National Causes of Death
Register and data on incident stroke events from the National Hospital Discharge Register. Adjusted Hazard
ratios (HR) for total mortality were 2.61 (95% Conﬁdence interval 2.15–3.18) among 45–64 years-old men and
2.59 (2.03–3.29) in 65–74 years-old men. The corresponding HRs for women 45–64 years-of-age were 3.21
(2.47–4.19) and 3.12 (2.09–4.68) for those 65–74 years-old, respectively. Adjusted HRs for CVD mortality in the
45–64 years-old and 65–74 years-old groups were 2.67 (1.92–2.67) and 1.95 (1.33–2.86) in men, and 4.28
(2.29–7.99) and 2.67 (1.28–5.58) in women, respectively. Among men, the risk diﬀerence between never and
current smokers was 108/100.000 in the age-group 45–64 years, and 324/100.000 in the age group 65–74 years.
Among women the diﬀerences were 52/100.000 and 196/100.000, respectively. In conclusion, absolute risk
diﬀerence between never and current smokers are larger among the older age group. Smoking cessation
counseling should routinely target also older adults in primary health-care.
1. Introduction
Tobacco smoking causes many chronic diseases, such as many
cancers, cardiovascular disease (CVD) and chronic obstructive pul-
monary disease (COPD), and increases markedly all-cause mortality
(Mitchell et al., 2010; Doll et al., 2004). Even though the age-standar-
dized smoking prevalence has decreased worldwide during the past
three decades, the absolute number of smokers has increased with al-
most one billion daily smokers worldwide in 2012 (Ng et al., 2014).
Even though a number of the studies have shown the deleterious
eﬀect of smoking in the middle-aged population, less information is
available in older adults (Kelly et al., 2008; Myint et al., 2008; Parish
et al., 1995; Thun et al., 2013a; Gellert et al., 2012a). A recent meta-
analysis revealed that smoking, even among older adults, considerably
advances, and cessation delays, the risk of all-cause, CVD and cancer
death (Ordóñez-Mena et al., 2016; Mons et al., 2015; Müezzinler et al.,
2015). However, scientiﬁc evidence in regard the risk estimates of CVD,
cancer and all-cause mortality between middle-aged and older adults in
the same population cohort is scarce.
As the number of older adults is globally increasing, it must be of
great public health interest to get estimates of the association between
smoking, morbidity and mortality in the older adult population.
The objective of this study was to assess the relationship of smoking
habits with cancer, CVD and all-cause mortality and to compare whe-
ther the smoking related health risk diﬀers between late middle-age
(45–64 years) and older (65–74) people.
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2. Methods
2.1. Study participants
The National FINRISK Study has been conducted every ﬁve years
since 1972 in order to monitor cardiovascular and other non-commu-
nicable disease risk factors and other health related factors among the
Finnish adult population (Borodulin et al., 2015). An independent
random sample has been drawn from the national population register
for each survey. The samples were stratiﬁed by sex and 10-year age
categories according to the World Health Organization Multinational
Monitoring (WHO MONICA) of trends and determinants of CVD pro-
tocol (Vartiainen et al., 2010). The current study cohort consists of
participants who were aged 45–74 years sampled in 1997, 2002, and
2007 in ﬁve study areas (provinces of North Karelia and North Savo in
Eastern Finland, Turku-Loimaa area in Southwestern Finland, cities of
Helsinki and Vantaa in Southern Finland and Oulu province in Northern
Finland). People who participated more than once in the surveys are
included in their ﬁrst study cohort, and those with missing information
on any of the variables needed for the analysis or those with an acute
CHD, stroke event prevalent heart failure or cancer before the baseline
survey, were excluded from the analysis. The ﬁnal sample size of the
follow-up cohort consisted of 6516 men and 6514 women.
2.2. Baseline assessment of cardiovascular risk factors
A self-administered questionnaire was mailed to the participants in
advance. The questionnaire included standardized questions on health
behavior, including smoking habits, and other health related and so-
ciodemographic factors. Smoking habits were classiﬁed to three cate-
gories: never smokers, ex-smokers (stopped more than six months ago)
and current smokers (currently smoking or stopped smoking within the
last 6 months). Education level, measured as the total number of school
years, was divided into birth cohort-speciﬁc thirds. Marital status was
categorized according to married, unmarried, divorced or widowed. At
the study site, specially trained nurses checked that the questionnaire
was fully completed and measured height, weight, and blood pressure
using a standardized protocol (Vartiainen et al., 2010). Height and
weight were measured in light clothing without shoes and body mass
index (BMI) was calculated (kg/m2). Blood pressure was measured with
mercury sphygmomanometer twice in 1997 and three times in 2002
and 2007 from the right arm of the participant in a seated position after
at least 5 min of rest. The mean value of the ﬁrst and second systolic
blood pressure measurement was used in the analysis. After clinical
measurements, a venous blood specimen was taken for laboratory
analysis. Serum total cholesterol level was analyzed by using enzymatic
method. All laboratory analyses were done in the same central la-
boratory of the National Institute for Health and Welfare.
2.3. Outcome deﬁnition
The study cohort was followed up until the end of 2013. Mortality
data were obtained from the National Causes of Death Register. The
median follow-up time was 11.8 years. End points were deﬁned ICD-10
coding and the number of end point events during the follow-up was:
3454 deaths (all deaths), 1362 CVD deaths (ICD-10: I20-I25, R98, I61,
I63, not I636, I64) and 1172 cancer deaths (ICD-10: C00-C97).
2.4. Statistical analysis
Statistical analyses were performed with SAS for Windows 9.3
(Cary, NC). The Cox proportional hazards model was used to estimate
the association between smoking status at baseline and the risk for the
above mentioned endpoints during the follow-up. For each endpoint,
two models were applied: A: adjusted for age, study area and study
year; B: Model A with additional adjustments for BMI, total cholesterol,
systolic blood pressure, education and marital status. All analysis was
done separately for men and women, and by age-group, 45–64 years
and 65–74 years. Smoking status was treated as ordinal variable in the
model, and the statistical signiﬁcance of the diﬀerent smoking cate-
gories was tested in the same models, with the category never smoking
as reference group. The proportional hazards assumption in the Cox
model was tested graphically using Kaplan-Meier curves. The p-value
for statistical signiﬁcance was set as 0.05. Finally, the incidence rates
were calculated dividing the number of new cases by the follow-up time
of the people for each smoking category separately for sex and the two
age-groups. In addition, the corresponding 95% conﬁdence intervals for
each incidence rate was calculated.
2.5. Ethical issues
The study was conducted according to the Helsinki Declaration of
the World Medical Association. The study protocol was approved by the
ethics committee as deﬁned by the Finnish law during each study year.
All participants gave an informed consent. The study report is written
by following the STROBE guidelines for prospective cohort studies (Von
Elm et al., 2007).
3. Results
Table 1 shows the characteristics of the study population according
to sex and age-group at baseline. The prevalence of current smoking
was 30% in men 45–64 years-of-age and 15% in men 65–74 years-of-
age. The corresponding prevalence in women were as 18% and 7%,
respectively.
Multifactorial adjusted (age, area, study year, BMI, systolic blood
pressure, serum cholesterol, education and marital status) hazard ratios
(HR) for current smoking, compared to never smoking were 2.61 (95%
CI 2.15–3.18) among 45–64 years-old men and 2.59 (95% CI
2.03–3.29) in 65–74 years-old men (Table 2). The corresponding HRs
for women were 3.21 (95% CI 2.47–4.19) and 3.12 (95% CI 2.09–4.68),
respectively. Ex-smoking men, had a signiﬁcant 30–38% increased
hazard of total mortality, whereas a non-signiﬁcant increase in HRs was
found among older ex-smoker women only.
Multifactorial adjusted HRs of CVD mortality for current smoking in
the 45–64 years-old and 65–74 years-old men were 2.67 (95% CI
Table 1
Baseline characteristics of men and women aged 45–74 years in Finland, 1997,
2002 and 2007.
Age group (years) Men Women
45–64 65–74 45–64 65–74
(n=4885) (n=1631) (n=5209) (n=1305)
Age, mean (years) 55,0 69,0 54,7 69,2
Smoking, %
Never 37,6 37,0 65,2 79,8
Ex-smokers 32,8 47,6 17,1 12,8
Current 29,6 15,4 17,7 7,4
BMI, mean (kg/m2) 27,8 27,8 27,6 28,5
Cholesterol, mean
(mmol/l)
5,70 5,42 5,75 5,80
Systolic blood pressure,
mean (mmHg)
141,1 150,3 138,1 151,2
Education, %
Lowest tertile 31,9 28,8 32,5 31,0
Middle tertile 34,1 36,4 34,2 36,3
Highest tertile 34,0 34,9 33,4 32,6
Marital status, %
Married 79,3 78,9 72,0 54,2
Unmarried 9,7 7,7 7,9 7,9
Divorced 9,9 6,9 14,6 11,6
Widow 1,1 6,5 5,6 26,4
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1.92–2.67) and 1.95 (95% CI 1.33–2.86), 4.28 (95% CI 2.29–7.99) and
2.67 (95% CI 1.28–5.58) in women, respectively (Table 3). Ex-smokers
did not have an increased hazard of CVD mortality compared to never
smoking during the follow-up in women. In men the increase in the
hazard was not signiﬁcant.
Multifactorial adjusted HRs of cancer for current smoking were 3.00
(95% CI 2.15–4.18) among 45–64 years-old men and 4.15 (95% CI
2.82–6.10) in 65–74 years-old men. The corresponding HRs for women
45–64 years-of-age were 2.27 (95% CI 1.64–3.44) and 4.45 (95% CI
2.50–7.93) for the 65–74 years-old, respectively (Table 4). Past smoking
was statistically signiﬁcantly associated with an increased hazard of
cancer mortality in men 65–74 years-of-age only (HR 1.64; 95% CI
1.16–2.31).
Even though the HRs of deaths due to smoking were quite similar in
both age groups (Tables 2–4), the absolute diﬀerences were much larger
in the older age-group (Table 5). Among men, the risk diﬀerence be-
tween never and current smokers was 108/100.000 in the age-group
45–64 years, and 324/100.000 in the age group 65–74 years. Among
women the diﬀerences were 52/100.000 and 196/100.000, respec-
tively. In both sexes, cancer mortality was only slightly higher among
never-smokers in the older age group, compared to the smokers in the
younger age group.
4. Discussion
Smoking related hazard of all-cause mortality was fairly similar in
the 45–64 years-old and 65–74 years-old age groups, in cardiovascular
mortality the hazard was higher in the younger age group and in cancer
mortality in the older age group. Absolute risk diﬀerence between never
and current smokers, however, were much larger among the older age
group.
The following two examples demonstrate the negative public health
eﬀect of tobacco smoking: (i) Cancer mortality among never smokers in
the older age group was fairly similar with the current smokers in the
younger age group, i.e. smoking increases the risk of cancer death as
much as 10 years of age. (ii) Men have higher CVD mortality than
women, in general, but among smoking women CVD mortality was
nearly as high as among never smoking men, i.e. in CVD mortality
smoking is quite similar risk factor as male gender.
Our ﬁndings in regard all-cause mortality in 45–74 years-old men
and women who were smoking at baseline parallels the ones of studies
among diﬀerent population groups of similar age (Thun et al., 2013b;
Doll et al., 1994; Pirie et al., 2013; Jha et al., 2013; Nash et al., 2017).
In a pooled data analysis from ﬁve contemporary cohort studies in the
United States among men 55 to 74 years of age and women 60 to
Table 2
Hazard ratios for total mortality among men and women according to baseline
smoking status, with various forms of adjustment, Finland, 1997–2013.
Model Aa Model Bb
HR (95% CI) HR (95% CI)
Men 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 1.31 (1.06–1.62) 1.30 (1.05–1.60)
Current smokers 2.86 (2.36–3.47) 2.61 (2.15–3.18)
P for trend < 0.001 <0.001
Men 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 1.42 (1.16–1.73) 1.38 (1.13–1.69)
Current smokers 2.55 (2.02–3.23) 2.59 (2.03–3.29)
P for trend < 0.001 <0.001
Women 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 0.93 (0.63–1.39) 0.96 (0.64–1.43)
Current smokers 3.09 (2.39–4.00) 3.21 (2.47–4.19)
P for trend < 0.001 <0.001
Women 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 1.27 (0.86–1.88) 1.27 (0.86–1.88)
Current smokers 2.85 (1.92–4.23) 3.12 (2.09–4.68)
P for trend < 0.001 <0.001
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Adjusted for age, area, survey year.
b Additional adjustments for body mass index, serum cholesterol, systolic
blood pressure, education and marital status.
Table 3
Hazard ratios for cardiovascular disease mortality among men and women
according to baseline smoking status, with various forms of adjustment,
Finland, 1997–2013.
Model Aa Model Bb
HR (95% CI) HR (95% CI)
Men 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 1.28 (0.90–1.83) 1.19 (0.83–1.71)
Current smokers 3.02 (2.18–4.18) 2.67 (1.92–3.72)
P for trend < 0.001 <0.001
Men 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 1.20 (0.89–1.63) 1.15 (0.85–1.56)
Current smokers 1.98 (1.36–2.89) 1.95 (1.33–2.86)
P for trend 0.001 0.002
Women 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 0.39 (0.09–1.62) 0.37 (0.09–1.59)
Current smokers 3.47 (1.91–6.29) 4.28 (2.29–7.99)
P for trend < 0.001 <0.001
Women 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 0.71 (0.32–1.56) 0.72 (0.33–1.59)
Current smokers 2.13 (1.04–4.37) 2.67 (1.28–5.58)
P for trend 0.064 0.017
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Adjusted for age, area, survey year.
b Additional adjustments for body mass index, serum cholesterol, systolic
blood pressure, education and marital status.
Table 4
Hazard ratios for cancer mortality among men and women according to base-
line smoking status, with various forms of adjustment, Finland, 1997–2013.
Model Aa Model Bb
HR (95% CI) HR (95% CI)
Men 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 1.40 (0.98–1.99) 1.40 (0.98–2.00)
Current smokers 3.08 (2.22–4.27) 3.00 (2.15–4.18)
P for trend < 0.001 <0.001
Men 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 1.69 (1.20–2.38) 1.64 (1.16–2.31)
Current smokers 3.91 (2.68–5.70) 4.15 (2.82–6.10)
P for trend < 0.001 <0.001
Women 45–64 years
Never 1 Ref 1 Ref
Ex-smokers 1.00 (0.61–1.65) 0.98 (0.59–1.61)
Current smokers 2.37 (1.64–3.41) 2.37 (1.64–3.44)
P for trend < 0.001 <0.001
Women 65–74 years
Never 1 Ref 1 Ref
Ex-smokers 1.48 (0.78–2.79) 1.42 (0.74–2.70)
Current smokers 4.13 (2.36–7.21) 4.45 (2.50–7.93)
P for trend 0.064 <0.001
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Adjusted for age, area, survey year.
b Additional adjustments for body mass index, serum cholesterol, systolic
blood pressure, education and marital status.
N.C. Barengo, et al. Preventive Medicine Reports 14 (2019) 100875
3
74 years of age, (Thun et al., 2013b) all-cause mortality was at least
three times as high among current smokers than among those who had
never smoked. Lower risk estimates compared with ours were found in
some previous studies and meta-analysis (LaCroix et al., 1991; Gellert
et al., 2012b). LaCroix et al. found that smokers' mortality rates were
twice those of never smokers in a prospective study of 7178 persons
aged 65 years or older (LaCroix et al., 1991). Finally, The recent ﬁnd-
ings of the Consortium on Health and Ageing: Network of Cohorts in
Europe and the U.S. (CHANCES) that included 489,056 participants
aged ≥60 years at baseline from 22 population-based cohort studies,
also from the Finrisk Study, revealed that current smokers had 2-fold
and former smokers had 1.3-fold increased mortality compared with
never smokers (Müezzinler et al., 2015). Even though some data of our
study were included in the results of the CHANCES meta-analysis, their
follow-up ended in 2007, whereas our study included information on
follow-up time and events until the end of 2013. In our study, former
smoking was signiﬁcantly associated with an increased hazard of total
mortality among older men only.
Only a few prospective cohort studies have been published on the
association of smoking with CVD mortality speciﬁcally focused on older
adult populations (Gellert et al., 2012b; Beer et al., 2011; Gellert et al.,
2013; Iso et al., 2005). A recent random eﬀects meta-analysis of the
association of smoking status with CVD mortality yielded a summary
hazard ratio of 2.07 (95% CI 1.82 to 2.36) for current smokers and 1.37
(1.25 to 1.49) for former smokers compared with never smokers (Mons
et al., 2015). Our results are basically in line with these ﬁndings,
however, the hazard ratios among older women were much higher
compared with the ﬁndings of that particular meta-analysis. Moreover
our ﬁndings support results of a meta-analysis of 19 population-based
prospective cohort studies with individual participant data for 897,021
European and American adults (46–74 years-old) revealing that
smoking even among older adults' advances and cessation delays the
hazard of developing and dying from cancer (Ordóñez-Mena et al.,
2016).
There were two major changes during the study period in the
Finnish Tobacco Act, passed in 1976 in an eﬀort to reduce smoking
among Finns (Heloma et al., 2012). In 2004, the indoor smoking ban
was extended to all restaurants in Finland and in 2010, the public
display of cigarette products at shops was banned completely (Heloma
et al., 2012; Männistö et al., 2016). Thus, the results observed in
45–64 years-old ex-smoking women may be due to a shorter smoking
exposure time. Furthermore, a very recent study of randomly selected
pregnancies from1987 to 2011 observed a reduction in active cigarette
smoking during pregnancy among women aged ≥30 years in Finland
(Männistö et al., 2016). This may explain partially our ﬁndings in that
particular group.
Surprisingly, unlike most previous studies, we did not ﬁnd a higher
hazard of death among men compared with women. (Kelly et al., 2008;
Myint et al., 2008; Parish et al., 1995; Gellert et al., 2012a; Ordóñez-
Mena et al., 2016; Mons et al., 2015; Müezzinler et al., 2015; Thun
et al., 2013b) Moreover, the hazard of death seemed to be higher in
women in most of our models. However, it has to be kept in mind that
the 95% conﬁdence intervals of the hazards were less precise in women
and overlapped with the corresponding conﬁdence intervals of the
hazard ratios in men indicating no statistically signiﬁcant diﬀerence in
the hazard of death between sexes. In addition, as outlined by Thun
et al., one possible reason for the increased relative risk of dying may be
that in contemporary birth cohorts women had typically started
smoking in their teenage whereas in earlier birth cohorts range of age at
initiation was wider (Thun et al., 2013a).
Relative eﬀect of smoking is higher, but the absolute mortality is
lower in women. As smoking prevalence has decreased in men and
increased in women in both the US and Finland, this result can probably
be expected as the pathophysiological mechanism between smoking
and adverse health eﬀects are the same for both men and women.
Our results challenge the primary health-care systems to implement
smoking cessation activities among older adult population. Previous
studies have eﬀectively shown that smoking cessation is highly and
rapidly beneﬁcial for health even at the oldest ages (Gellert et al.,
2012a). As older adults who smoke often believe that they are too old to
receive a beneﬁt from stop smoking, interventions targeting them may
need to be age-tailored as their motivation and behavioral certainly are
diﬀerent compared with younger population groups (Lam, 2012).
One of the main strengths of our study was that our analyses were
conducted among large, representative population samples of middle-
aged and older men and women. The follow-up was comprehensive and
relatively long, enabling to apply the results directly to the general
population.
However, several limitations of this study need to be considered.
The assessment of our cohort is limited to a single examination per-
formed when the participants entered the study as it is usual for large
prospective studies. Information on smoking status is available only at
Table 5
Age-adjusted all-cause, cardiovascular disease and cancer mortality rates in men and women according to baseline smoking status, Finland, 1997–2013.
All-cause mortality Cancer mortality CVDc mortality
Ratea (95% CI)b Rate (95% CI) Rate (95% CI)
Men (45–64 years-old)
Never smokers 75 (63–86) 25 (19–32) 26 (19–33)
Ex-smokers 103 (88–117) 37 (28–45) 35 (27–44)
Current smokers 183 (162–203) 65 (52–77) 64 (51–76)
Men (65–74 years-old)
Never smokers 250 (211–289) 78 (56–100) 115 (88–141)
Ex-smokers 335 (294–376) 128 (103–154) 131 (105–156)
Current smokers 574 (474–674) 276 (207–345) 203 (144–263)
Women (45–64 years-old)
Never smokers 40 (33–46) 22 (17–26) 7 (5–10)
Ex-smokers 29 (18–39) 19 (10–27) 2 (0–5)
Current smokers 92 (74–110) 43 (31–55) 18 (10–26)
Women (65–74 years-old)
Never smokers 173 (148–198) 55 (41–69) 73 (57–90)
Ex-smokers 196 (127–265) 76 (33–119) 44 (11–77)
Current smokers 369 (241–496) 207 (112−303) 104 (36–171)
Abbreviations: CI, conﬁdence interval; CVD, cardiovascular disease.
a Per 10.000 person-years.
b Conﬁdence interval.
c Cardiovascular disease.
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baseline, and therefore any modiﬁcation during follow up cannot be
accounted for. In general, this can lead to non-diﬀerential mis-
classiﬁcation bias of the exposure, which in most cases could bias re-
sults towards no diﬀerences between exposure groups. A relative large
proportion of smokers have quit during the follow-up but starting
smoking after the age of 45 years is very rare. In addition, assessing
smoking habits by questionnaire may lack validity of the participants'
responses in the questionnaires. No information on package-years of
smokers or ex-smokers was available in our study participants, either.
However, self-reported smoking habits are commonly used in epide-
miological studies and seem to be rather accurate when compared with
biochemical markers of tobacco use. Another limitation is the lack of
detailed information on smoking cessation. For example, diﬀerences in
the HR for former versus never smoking in men and women may reﬂect
diﬀerences in the age at which men and women quit smoking in this
population. Thus, future studies may include information on age of
cessation to the statistical models upon availability of data.
Finally, we cannot completely exclude either eﬀects of residual
confounding attributable to the measurement error in the assessment of
confounding factors or some unmeasured dietary factors.
In conclusion, smoking increases the hazard of all-cause, CVD and
cancer mortality both middle-age population and older adults.
Compared with younger age groups, the relative risk of death for cur-
rent smokers is similar for older age groups as health among non-
smokers deteriorates as well. However, absolute risk diﬀerence between
never and current smokers are larger among the older age groups due to
their increased overall risk of death.
Smoking cessation seems to be beneﬁcial also among older adult
population in order to reduce CVD, cancer and total mortality. Thus, we
recommend to advice routinely older adults to quit smoking and to
implement special tailored interventions to reduce the smoking pre-
valence among that speciﬁc age group.
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